| HOME >> MEDICINE >> TECHNOLOGY |
The following tables illustrate for the three months ended December 31, 2012 the percentage changes in net sales by reportable segments and by Specialty Phosphates product lines compared with the same period of the prior year, including the effect of selling price and volume/mix changes upon revenue: Reportable Segments PriceVolume/Mix TotalSpecialty Phosphates US & Canada
-0.1%3.8%3.7%Specialty Phosphates Mexico
-5.0%-5.8%-10.8%Total Specialty Phosphates
-1.5%1.0%-0.5%GTSP & Other
-11.7%13.9%2.2%Total
-2.7%2.5%-0.2%Note: Includes Kelatron/AMT benefit of 3.6% in Specialty Phosphates US & Canada Volume/Mix and 2.6% in Total Specialty Phosphates Volume/MixSpecialty Phosphates Product Lines PriceVolume/Mix TotalSpecialty Ingredients
-1.1%-0.6%-1.7%Food & Technical Grade PPA
-4.7%8.1%3.4%STPP & Detergent Grade PPA
1.5%-1.5%0.0%Note: Includes Kelatron/AMT benefit of 3.9% in Specialty Ingredients Volume/MixSummary Profit & Loss Statement – Full Year INNOPHOS HOLDINGS, INC. AND SUBSIDIARIESCondensed Consolidated Statement of Operations (Unaudited)(Dollars In thousands, except per share amounts or share amounts) Year Ended December 3120122011Net sales
$862,399$810,487Cost of goods sold
684,979605,172Gross profit
177,420205,315Operating expenses:Selling, general and administrative
64,32065,380Research & development expenses
3,1072,923Total operating expenses
67,42768,303Operating income
109,993137,012Interest expense, net
5,9775,726Foreign exchange (gain) loss
(1,957)875Income before income taxes
105,973130,411Provision for income taxes
31,78343,889Net income
$74,190$86,522Dilu
'/>"/>
| SOURCE Innophos Holdings, Inc. Copyright©2012 PR Newswire. All rights reserved |